NorthStrive Biotherapeutics
Phase 1NorthStrive Biosciences is advancing a first-in-class approach to address obesity’s pressing issue of preserving muscle while on GLP-1 treatments.
Founded
2021
Focus
Biologics
About
NorthStrive Biosciences is advancing a first-in-class approach to address obesity’s pressing issue of preserving muscle while on GLP-1 treatments.
Funding History
1Total raised: $15M
Seed$15MUndisclosedMar 15, 2023
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile